Search research articles
Contact Us
Filters
Showing results (151-160 of 171) with videos related to
Page
of 18
Sort By:
European Journal of Clinical Nutrition
|
February 27, 2014
Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study)
D J Costa, P Marteau, M Amouyal, et al.
Gastroenterology
|
June 2, 2000
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
J F Colombel, N Ferrari, H Debuysere, et al.
Alimentary Pharmacology & Therapeutics
|
January 24, 2017
Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus
L Vuitton, L Peyrin-Biroulet, J F Colombel, et al.
International Journal of Food Microbiology
|
December 16, 1998
Demonstration of safety of probiotics -- a review
S Salminen, A von Wright, L Morelli, et al.
Journal of Crohn'S & Colitis
|
December 3, 2010
Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis
G R D'Haens, A Kovács, P Vergauwe, et al.
Gut
|
May 17, 2007
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine
G Vernier-Massouille, J Cosnes, M Lemann, et al.
Gut
|
September 11, 2015
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
L Vuitton, P Marteau, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics
|
May 28, 2011
Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort
A Vienne, T Simon, J Cosnes, et al.
Journal of Crohn'S & Colitis
|
December 22, 2010
European evidence-based Consensus on the management of ulcerative colitis: Current management
S P L Travis, E F Stange, M Lémann, et al.
Alimentary Pharmacology & Therapeutics
|
August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
M Allez, S Vermeire, N Mozziconacci, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 171) with videos related to
Sort By:
Page
of 18
European Journal of Clinical Nutrition
|
February 27, 2014
Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study)
D J Costa, P Marteau, M Amouyal, et al.
Gastroenterology
|
June 2, 2000
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
J F Colombel, N Ferrari, H Debuysere, et al.
Alimentary Pharmacology & Therapeutics
|
January 24, 2017
Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus
L Vuitton, L Peyrin-Biroulet, J F Colombel, et al.
International Journal of Food Microbiology
|
December 16, 1998
Demonstration of safety of probiotics -- a review
S Salminen, A von Wright, L Morelli, et al.
Journal of Crohn'S & Colitis
|
December 3, 2010
Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis
G R D'Haens, A Kovács, P Vergauwe, et al.
Gut
|
May 17, 2007
Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine
G Vernier-Massouille, J Cosnes, M Lemann, et al.
Gut
|
September 11, 2015
IOIBD technical review on endoscopic indices for Crohn's disease clinical trials
L Vuitton, P Marteau, W J Sandborn, et al.
Alimentary Pharmacology & Therapeutics
|
May 28, 2011
Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort
A Vienne, T Simon, J Cosnes, et al.
Journal of Crohn'S & Colitis
|
December 22, 2010
European evidence-based Consensus on the management of ulcerative colitis: Current management
S P L Travis, E F Stange, M Lémann, et al.
Alimentary Pharmacology & Therapeutics
|
August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
M Allez, S Vermeire, N Mozziconacci, et al.
Page
of 18